Search
for
Sort by
Research 151–180 of 655
- Polycystic ovary syndrome
- Chemical pharmacotherapy options for managing adult acne
- Recommendations of endocrine treatment for patients with gender dysphoria
- Pharmacological management of polycystic ovary syndrome
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Symptom management in inflammatory bowel disease
- Clinical manifestations of polycystic ovary syndrome
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Transgender and Migraine
- YouTube and the implementation and discontinuation of the oral contraceptive pill: A mixed-method content analysis
- Women with alopecia exhibit a higher risk for thyroid cancer: A nationwide cohort study
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Androgens in SARS-CoV-2 Coronavirus Infections
- Endocrine disorders and hormonal therapy for adolescent acne
- Cardiovascular risk markers and thyroid status in young Indian women with polycystic ovarian syndrome: A case-control study
- Recent therapeutic developments for acne
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Ottawa, Ontario, Canada, February 13–16, 2013
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Cardiovascular disease risk in women with hyperandrogenism, oligomenorrhea/menstrual irregularity or polycystic ovaries (components of polycystic ovary syndrome): a systematic review and meta-analysis
- A Case of Rhupus with Rowell Syndrome
- Diagnosis and treatments of hirsutism: where are we?
- Menopause
- THE PEDIATRICIAN AND THE SEXUALLY ACTIVE ADOLESCENT
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
- Diagnostik und Therapie der kutanen Androgenisierung im klimakterischen Übergang sowie in der Peri- und Postmenopause: Hirsutismus und Alopezie
- Hair Growth After Gefitinib Treatment
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Efficacy of tofacitinib in pediatric alopecia universalis